← All companies

APUS

Apimeds Pharmaceuticals US, Inc.

APUS NYSE Pharmaceutical Preparations EDGAR ↗

$4.85

-0.30 -5.83%

Key statistics

from XBRL data in SEC filings

Market cap

$73.2M

Revenue (TTM)

—

Net income (TTM)

-$40.7M

EPS (TTM)

$-2.76

P/E ratio

—

Dividend yield

—

Free cash flow

-$8.98M

Cash

$980K

Total assets

$141M

Gross margin

—

52-week range

$4.15 – $59.70

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 13, 2026 10-Q Quarter ended 2026-03-31 May 26, 2026 8-K Director or officer change May 5, 2026 10-K Fiscal year ended 2025-12-31 May 4, 2026 8-K Entered a material agreement; Director or officer change; Other events May 4, 2026 8-K Delisting notice or listing-rule failure Apr 22, 2026 8-K Other events Apr 16, 2026 8-K/A Director or officer change; Amended charter or bylaws; Other events Apr 9, 2026 8-K Director or officer change; Amended charter or bylaws; Other events Mar 26, 2026 8-K Director or officer change; Amended charter or bylaws; Other events Mar 25, 2026 8-K Other events Mar 16, 2026 8-K/A Completed an acquisition or disposition Feb 17, 2026 8-K Director or officer change Jan 2, 2026 8-K Director or officer change Dec 10, 2025 8-K/A Entered a material agreement; Modified rights of security holders; Amended charter or bylaws Dec 10, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity; Change in control; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Dec 2, 2025 8-K Director or officer change Nov 18, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Amended charter or bylaws Oct 16, 2025 10-Q Quarter ended 2025-06-30 Aug 19, 2025 8-K Regulation FD disclosure Jul 16, 2025 8-K Director or officer change Jun 5, 2025 8-K Entered a material agreement May 20, 2025 10-Q Quarter ended 2025-03-31 May 20, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure May 12, 2025 10-K/A Fiscal year ended 2024-12-31 May 2, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Amended charter or bylaws Apr 15, 2025

Other filings

NT 10-Q NOTIFICATION OF LATE FILING May 15, 2026 SCHEDULE 13D/A May 7, 2026 425 AMENDMENT NO. 1 TO FORM 8-K Apr 9, 2026 NT 10-K NOTIFICATION OF LATE FILING Mar 31, 2026 SCHEDULE 13D/A Mar 30, 2026 SCHEDULE 13D/A Mar 20, 2026 DEFM14C INFORMATION STATEMENT Feb 27, 2026 425 AMENDMENT NO. 2 TO FORM 8-K Feb 17, 2026 SCHEDULE 13G Feb 11, 2026 SCHEDULE 13D/A Jan 26, 2026 PREM14C INFORMATION STATEMENT Jan 16, 2026 425 CURRENT REPORT Dec 2, 2025